Try our Advanced Search for more refined results
Mergers & Acquisitions
-
December 17, 2025
DOJ Says Live Nation Can't Avoid Jury In Antitrust Case
The Justice Department wants a New York federal judge to force Live Nation to face a jury next year on allegations it bought, coerced and leveraged its way to live performance dominance, arguing in a newly unsealed brief that there are too many factual disputes to upstage the lawsuit.
-
December 17, 2025
Air Taxi Co. Settles SPAC Merger Price Suit For $17.75M
Stockholders of former air transport venture Blade Air Mobility Inc. have agreed to settle for $17.75 million a Delaware Chancery Court stockholder derivative suit accusing an officer and controlling investors of breaching their fiduciary duties in a take-public deal via a special purpose acquisition company.
-
December 17, 2025
UWM Nabs MSR-Focused REIT In $1.3B All-Stock Deal
Greenberg Traurig-advised mortgage lender UWM Holdings Corp. on Wednesday unveiled plans to acquire mortgage servicing rights-focused REIT Two Harbors Investment Corp., led by Jones Day, in an all-stock deal that boasts an equity value of $1.3 billion.
-
December 17, 2025
Edinburgh Trust Urges Shareholders To Nix Board Takeover Bid
British investment company Edinburgh Worldwide on Wednesday urged its shareholders to vote against proposals made by its biggest shareholder Saba Capital to revamp its board, in what it called an attempt to "take control on the cheap."
-
December 17, 2025
Blackstone Seals $5B Partnership With Israeli Asset Manager
Israel-based asset management and insurance company Phoenix Financial on Wednesday announced that it has entered into a strategic partnership with Simpson Thacher & Bartlett LLP-led private equity giant Blackstone under which the Israeli firm will invest up to $5 billion across a range of credit strategies.
-
December 17, 2025
Diageo To Exit Kenya In $2.3B Deal With Asahi
Guinness owner Diageo said Wednesday that it has agreed to sell its Kenyan subsidiary to Japanese rival Asahi in a $2.3 billion deal, marking its exit from the East African country.
-
December 17, 2025
Warner Bros. Board Rejects 'Inferior' Paramount Bid
Warner Bros. Discovery Inc. said Wednesday that its board has determined Paramount Skydance Corp.'s $108.4 billion hostile offer is not a "superior proposal" to the company's pending $82.7 billion agreement with Netflix.
-
December 17, 2025
Finance Co. Gets Extra Time To Make £523M UK Credit Biz Bid
Britain's merger regulator has extended the deadline of U.S. finance group BasePoint Capital LLC to table a £523 million ($697 million) bid for International Personal Finance PLC, the U.K. credit provider said Wednesday.
-
December 17, 2025
Greencore's £1.2B Bakkavor Deal To Complete After CMA OK
Irish food manufacturer Greencore said Wednesday that it expects its £1.2 billion ($1.6 billion) acquisition of rival Bakkavor to complete in January after the U.K.'s competition authority abandoned its probe amid antitrust fixes proposed by the sides.
-
December 16, 2025
Judge Skeptical Of Trump-Tied SPAC's Defense In SEC Suit
A former Trump business associate appeared unlikely to win early dismissal of a U.S. Securities and Exchange Commission suit accusing him of hiding advanced merger discussions with the president's media company from SPAC investors in 2021, as a federal judge wondered Tuesday how the talks could be considered immaterial.
-
December 16, 2025
Va. Judge Advances Most Claims In Stelara Antitrust Case
A Virginia federal judge has allowed health insurer CareFirst's anticompetition and patent fraud claims against Johnson & Johnson to move forward in a case alleging anticompetitive behavior in relation to the immunosuppressive drug Stelara, while letting the pharmaceutical giant escape some claims of misrepresentation.
-
December 16, 2025
The Most Important Healthcare And Life Science Deals Of 2025
Attorneys taking stock of 2025 spoke to Law360 about the most important deals of the year, including Pfizer’s high-profile acquisition of Metsera and transactions in outpatient services and gene therapy.
-
December 16, 2025
Trends That Shaped Healthcare Dealmaking In 2025
With 2025 coming to a close, Law360 Healthcare Authority asked attorneys focused on healthcare deals for their take on the trends that influenced dealmaking over the last 12 months.
-
December 16, 2025
PE Giant KKR Plugs $220M Into Dubai-Based Premialab
Data, analytics and risk management solutions provider Premialab, advised by A&O Shearman, on Tuesday revealed that it received a $220 million growth investment from Gibson Dunn & Crutcher LLP-led private equity giant KKR.
-
December 16, 2025
JP Morgan PE Group's Latest Fund Exceeds Target At $1.44B
J.P. Morgan Asset Management's private equity group closed its 12th flagship fund, PEG Global Private Equity XII, above its $1.25 billion target at $1.44 billion, the firm announced Tuesday.
-
December 16, 2025
Kering, Ardian Form $900M JV At Luxury NYC Property
French luxury group Kering said Tuesday it has completed another real estate joint venture with private equity firm Ardian, expanding a partnership launched earlier this year with a $900 million deal for a Fifth Avenue retail property in New York City.
-
December 15, 2025
Del. Justices Put ITG On Hook For $250M Reynolds Settlement
Delaware's Supreme Court stubbed out an eight-year ITG Brands LLC legal battle to avoid paying R.J. Reynolds more than $250 million to cover health-related settlement payments to Florida after ITG's acquisition of four of the cigarette company's brands, according to a ruling issued Monday.
-
December 15, 2025
Fast-Track Sale Timeline Denied In Furniture Co. Ch. 11
A Delaware bankruptcy judge rejected an expedited timeline for the sale of the assets of home furnishing retailer American Signature Furniture, finding that the proposed 34-day process would not give enough time for an investigation of insider claims and the appointment of a consumer privacy ombudsman.
-
December 15, 2025
Cencora Pays $5B For Majority Stake Of OneOncology
Pharmaceutical company Cencora Inc. unveiled plans Monday to acquire a majority stake in cancer care company OneOncology for $5 billion, buying interest from private equity shop TPG in a deal built by three law firms.
-
December 15, 2025
Juventus Rejects Crypto Firm Tether's Bid, Stock Soars
The owners of Italian football club Juventus rejected an unsolicited buyout bid from crypto firm Tether, saying there is "no intention" of selling shares and helping to push the club's market capitalization above $1 billion as its stock surged Monday.
-
December 15, 2025
Investment Firms Nab Quipt Home Medical In $260M Deal
Medical equipment provider Quipt Home Medical Corp. on Monday announced plans to go private after being purchased by a special purpose acquisition vehicle funded by investment firms Kingswood Capital Management and Forager Capital Management in a deal that values the company at $260 million and was built by three law firms.
-
December 15, 2025
Catching Up With Delaware's Chancery Court
Litigation in Delaware's Court of Chancery sprawled from a dispute over control of banana plantations along Africa's Congo River to a fight over the late musician Prince's estate last week. Along the way, a court ruling rejected a motion for a quick decision favoring Blue Bell Creameries director and officer calls for liability releases in a tainted ice cream saga that dates to 2015.
-
December 15, 2025
Europe Seen As Top Tech M&A Prospect For 2026
Europe has quietly become tech dealmakers' top hunting ground, as global tech mergers and acquisitions values skyrocketed more than 72% in the first three quarters of the year, according to a new global survey from Morrison Foerster LLP.
-
December 15, 2025
McDermott-Led Sobi To Buy US Gout Specialist For $1.5B
Swedish biopharma company Swedish Orphan Biovitrum AB said Monday that it has agreed to acquire Arthrosi Therapeutics Inc., a specialist in treatment for gout, for up to $1.5 billion in a deal guided by McDermott.
-
December 12, 2025
Live Nation Consumers Get Class Certified In Antitrust Case
A California federal judge Friday certified a class of consumers accusing Live Nation of monopolizing the live entertainment industry, rejecting the company's argument that there aren't common issues that predominate over individual ones and adopting a tentative ruling he issued earlier this month.
Expert Analysis
-
The Metamorphosis Of The Major Questions Doctrine
The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.
-
Biotech Collaborations Can Ease Uncertainty Amid FDA Shift
As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.
-
Series
Playing Mah-Jongg Makes Me A Better Mediator
Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.
-
Business Court Bill Furthers Texas' Pro-Corporate Strategy
The Texas Legislature's recent bill to enhance corporate protections and expand access to the Texas Business Court by refining its jurisdictional standards is just the latest step in the state's playbook for becoming the new center of corporate America, say attorneys at Katten.
-
FTC Staff Cuts Unlikely To Curb Antitrust Enforcement Agenda
While Federal Trade Commission Chair Andrew Ferguson's recent commitment to reducing agency staff may seem at odds with the Trump administration's commitment to antitrust enforcement, a closer analysis shows that such reductions have little chance of derailing the president's efforts, say attorneys at Squire Patton.
-
Series
Law School's Missed Lessons: Navigating Client Trauma
Law schools don't train students to handle repeated exposure to clients' traumatic experiences, but for litigators practicing in areas like civil rights and personal injury, success depends on the ability to view cases clinically and to recognize when you may need to seek help, says Katie Bennett at Robins Kaplan.
-
Opinion
4 Former Justices Would Likely Frown On Litigation Funding
As courts increasingly confront cases involving hidden litigation finance contracts, the jurisprudence of four former U.S. Supreme Court justices establishes a constitutional framework that risks erosion by undisclosed financial interests, says Roland Eisenhuth at the American Property Casualty Insurance Association.
-
Takeaways From EU's Review Of Merger Control Guidelines
The European Commission’s newly launched consultation on the European Union’s merger guidelines will explore whether and how merger control should consider key policy objectives, such as innovation, investment incentives and security, say lawyers at Latham.
-
How Attys Can Use AI To Surface Narratives In E-Discovery
E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.
-
Identifying Data Center Investment Challenges, Opportunities
The role of data centers is expanding, as are new opportunities for private capital investors, but there are issues to consider, including finance models and contract complexity, as well as power supply, cyber threat resilience and data sovereignty, say lawyers at Ropes & Gray.
-
Leveraging Diligence Findings For Better Life Sciences Deals
Life sciences parties should utilize due diligence strategically to review and draft deal documents, address issues identified during the diligence, and craft solutions to achieve the party's transactional goals, says Anna Zhao at Gunner Cooke.
-
IP Due Diligence Tips For AI Assets In M&A Transactions
Artificial intelligence systems' integration into business operations creates new considerations for intellectual property due diligence in mergers and acquisitions and financing transactions, and implementing a practical approach to identifying AI assets can help avoid litigation and losses, say Armin Ghiam and Senna Hahn at Hunton.
-
AbbVie Frees Taxpayers From M&A Capital Loss Limitations
The U.S. Tax Court’s June 17 opinion in AbbVie v. Commissioner, finding that a $1.6 billion break fee was an ordinary and necessary business expense, marks a pivotal rejection of the Internal Revenue Service’s position on the tax treatment of termination fees related to failed mergers or acquisitions, say attorneys at Holland & Knight.
-
Capital One Deal Approval Lights Up Path For Bank M&A
The federal banking regulators' recent approval of Capital One's acquisition of Discover signals the agencies' willingness to approve large transactions and a more favorable environment generally for bank mergers under the Trump administration, say attorneys at Arnold & Porter.
-
Series
Playing The Violin Makes Me A Better Lawyer
Playing violin in a string quartet reminds me that flexibility, ambition, strong listening skills, thoughtful leadership and intentional collaboration are all keys to a successful legal practice, says Julie Park at MoFo.